Navigation Links
Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
Date:8/28/2009

ts containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied by such statements and information include, but are not limited to, the risks and uncertainties that: we, together with our collaborative partners, may not be able to successfully develop and obtain regulatory approval for vernakalant (iv) or vernakalant (oral) in the treatment of atrial fibrillation or any other current or future products in our targeted indications; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and sales capabilities and the costs of launching our products may be greater than anticipated; we rely on third parties for the continued supply and manufacture of vernakalant (iv) and vernakalant (oral) and we
'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
2. Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth
3. Cardiome to Hold Conference Call
4. Cardiome Announces Management Transition
5. Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
6. Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective
7. Cardiome Reports First Quarter Results
8. Cardiome to Hold Conference Call
9. CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
10. Cardiome Reports 2008 Results
11. CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Reinberg HealthDay Reporter TUESDAY, ... reduce the need for blood transfusions might also protect the ... erythropoietin (EPO), which stimulates red blood cell production, appears to ... lead researcher Dr. Petra Huppi, a professor of pediatrics and ... "The real test of whether EPO protects the brains of ...
(Date:8/27/2014)... eat over 10 portions a week of tomatoes have ... cancer, new research suggests. , With 35,000 new cases ... prostate cancer is the second most common cancer in ... which some experts believe is linked to a Westernised ... and lifestyle recommendations reduces risk of prostate cancer, researchers ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 DISCcert has ... to take place Sept 10th, 17th, 24th, and Oct ... series will receive a certification seal that will allow ... The program consists of four weekly one-hour webinar sessions. ... complete, and are offered individual coaching time. , ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Global leaders ... policy will gather at the Minneapolis Marriott Northwest on ... worldwide explosion of robotics and autonomous systems at the ... In recognition of the wide variety of ways robotics ... & Expo created nine different tracks of content. For ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Main Street Dental ... announcing its advice on how long a toothbrush can be ... best oral care for teeth and gums. , “Replacing a ... fairly regular basis," says Dr. Harvey Schwartz, owner of Main ... every three to four months." , Dr. Schwartz explains that ...
Breaking Medicine News(10 mins):Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3Health News:Fighting prostate cancer with a tomato-rich diet 2Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 2Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 3Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 4Health News:Robotics Alley, LifeScience Alley Partner on Health Care & Medical Device Track 2Health News:Robotics Alley, LifeScience Alley Partner on Health Care & Medical Device Track 3Health News:Robotics Alley, LifeScience Alley Partner on Health Care & Medical Device Track 4Health News:Robotics Alley, LifeScience Alley Partner on Health Care & Medical Device Track 5Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Advises on the Best Time to Replace a Toothbrush 2
... Health and the University of Colorado Denver have discovered a ... acute lung injury. Acute lung injury (ALI) is often caused ... in the blood, and fluid in the lungs. It is ... afflicting almost 200,000 people in the United States each year, ...
... Pharos Innovations, a pioneer in,assisting clients to ... a device-free remote monitoring platform,today announced it is ... of two key appointments in medical informatics and ... http://www.newscom.com/cgi-bin/prnh/20080306/AQTH086LOGO ) , ...
... N.Y., Jan. 16 Bausch & Lomb, the ... Valenti, III, will join Bausch & Lomb as ... month."Pete possesses deep leadership experience, as well as ... Stuart Heap, corporate vice president and global president, ...
... 16 /PRNewswire-FirstCall/ - Thomas E. Gardner, Chairman, announced ... appointed to the NUCRYST Pharmaceuticals, Board of Directors. ... Executive Officer of The Westaim Corporation ("Westaim"), NUCRYST,s ... common shares. Prior to his appointment as President ...
... 16 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... of medical devices worldwide, today announced updates on ... and international markets in,2009. , ... of ten products, achieving the goals,for new product ...
... in Guangdong ProvincePROVO, Utah, Jan. 15 Nu Skin ... that it has received official notification from the Chinese ... selling activities in four cities in the Guangdong province ... Skin Enterprises the opportunity to offer a direct selling ...
Cached Medicine News:Health News:Gene associated with reduced mortality from acute lung injury 2Health News:Pharos Innovations Strengthens Leadership Team, Informatics Program 2Health News:Pharos Innovations Strengthens Leadership Team, Informatics Program 3Health News:Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care 2Health News:NUCRYST Pharmaceuticals appoints a new director 2Health News:NUCRYST Pharmaceuticals appoints a new director 3Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 2Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 3Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 4Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 5Health News:Nu Skin Enterprises Receives Broader Direct Selling Authorization in China 2
(Date:8/26/2014)... BLUE BELL, Pa. , Aug. 26, 2014 ... PRA Health Sciences, largest office worldwide. PRA, a leading global Contract ... and Fort Washington locations into ... . The new office opened this week and marks the ... an exciting time for us at PRA," said Harris Koffer ...
(Date:8/26/2014)... , Aug. 26, 2014 Biomedical Research ... has been named to the prestigious 2014 Inc. 500 ... honored to be included on this prestigious list and ... Chris Jacob , Biomedical Research Laboratories, CEO. "Today,s ... further serves to validate the hard work and talent ...
(Date:8/26/2014)... , Aug. 26, 2014 ... of the "Global Veterinary Diagnostics Market 2014-2018" ... Veterinary diagnostics include various tests, which are used ... livestock producers, and biomedical researchers are mainly availing ... testing (Deoxyribonucleic Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, ...
Breaking Medicine Technology:PRA Health Sciences Expands in Pennsylvania 2Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 3
Chemically Resistant Sealing Mat for 96ch, 1.1ml or 2.0ml, Deep Well, Round Available Sterile...
Sealing Mat for 96-well PCR Plate, Natural...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: